Cytonus Therapeutics has developed a first-in-class “biologic drone” called the Cargocyte. The Cargocyte is a platform to deliver therapeutics in a precise, controlled, safe and reproducible manner. Cytonus’ innovative approach delivers on the long sought after promises of drug delivery, to deliver the right drug at the right dose to the right tissue.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $11.7M
Founded date: 2018
Investors 1
Date | Name | Website |
- | Creative V... | creativeve... |
Funding Rounds 1
Date | Series | Amount | Investors |
04.12.2023 | Series A | $11.7M | - |
Mentions in press and media 4
Date | Title | Description | Source |
09.01.2024 | Cytonus Therapeutics Enters Licensing Agreement with Medinno... | Cytonus obtains exclusive rights to Medinno’s HIEstem for the North American and MENA markets SAN D... | einpresswi... |
04.12.2023 | Cytonus Therapeutics garners $11.7M in Series A funding to c... | - | connect.or... |
04.12.2023 | Cytonus Raises $11.7M in Series A Financing | Cytonus Therapeutics, Inc., a San Diego, CA-based biotechnology company discovering and advancing no... | finsmes.co... |
- | Cytonus Therapeutics | “Cytonus - Cytonus” | fastfounde... |